Evidence map›Paper›PMID 29951058›Full record

ArticleFrontiers in immunology2018

Hsp70 Suppresses Mitochondrial Reactive Oxygen Species and Preserves Pulmonary Microvascular Barrier Integrity Following Exposure to Bacterial Toxins.

Xueyi Li, Yanfang Yu, Boris Gorshkov, Stephen Haigh, Zsuzsanna Bordan, Daniel Weintraub, Radu Daniel Rudic, Trinad Chakraborty, Scott A Barman, Alexander D Verin and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Xueyi LiVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Yanfang YuVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Boris GorshkovVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Stephen HaighVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Zsuzsanna BordanVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Daniel WeintraubVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Radu Daniel RudicDepartment of Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, GA, United States.
Trinad ChakrabortyInstitute for Medical Microbiology, Justus-Liebig University Giessen, Giessen, Germany.
Scott A BarmanDepartment of Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, GA, United States.
Alexander D VerinVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Yunchao SuDepartment of Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, GA, United States.
Rudolf LucasVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
David W SteppDepartment of Pharmacology and Toxicology, Medical College of Georgia at Augusta University, Augusta, GA, United States.
Feng ChenVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
David J R FultonVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, Georgia.
Augusta University · USNanjing Medical University · CNUniversity of Giessen · DE

Funding

Galectin-3: A mediator of vascular remodeling in pulmonary arterial hypertensionR01HL125926 · NHLBI · AUGUSTA UNIVERSITY · PI BARMAN, SCOTT A, FULTON, DAVID J · 2016 to 2025
$4.9M
Novel mechanistic pathways of cardiovascular disease in obesityR01HL124773 · NHLBI · AUGUSTA UNIVERSITY · PI FULTON, DAVID J, STEPP, DAVID W · 2015 to 2018
$2.2M
NHLBI NIH HHS R01 HL124773NHLBI NIH HHS R01 HL125926
6 · The paper itself

Abstract

Pneumonia is a leading cause of death in children and the elderly worldwide, accounting for 15% of all deaths of children under 5 years old.

Indexed as

endothelial barrierHsp70mitochondriapneumolysinreactive oxygen species

Identifiers

PMID29951058
PMCPMC6008539
OpenAlexW2806819460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.